Most Recent
Leading fundraising company Appco Australia Group is challenging a judge's decision to let a $85 million wage case move forward as a class action.
Luxury home builder Glenville has won an appeal of a ruling that shielded certain documents from production by legal professional privilege in a lawsuit against global packaging giant Amcor over liability for asbestos remediation at a former Amcor paper mill site in a Melbourne suburb.
The High Court has rejected a bid by biopharmaceutical company Samsung Bioepis Australia to challenge a ruling granting Pfizer preliminary discovery for a potential patent infringement case over autoimmune drug Enbrel.
Pharmaceutical giant Wyeth's has launched an "ambush" at the beginning of a trial after a nine-year long battle against several generic drug makers, alleging infringement of a second patent for its blockbuster Effexor-XR, a judge heard Monday.
Law firm Squire Patton Boggs is appealing a ruling that permanently stayed its case against technology startup GetSwift in favour of a competing class action.
In the wake of a major ruling approving a wage class action against fundraiser Appco, more "sham" contracting suits were launched Monday, this time against two international direct marketing companies.
A judge has denied a bid for summary judgment by Garmin Australia in a lawsuit brought by the GPS giant seeking $1.1 million allegedly owed under an agreement to supply its products for sale in Australia.
Commonwealth Bank of Australia will pay $700 million to settle claims of lax anti-money laundering oversight.
The Australian Building and Construction Commissioner has lost its challenge to a Federal Court decision dismissing allegations that the Construction, Forestry, Mining and Energy Union engaged in unlawful industrial action in Canberra in 2014.
A decade-long courtroom battle over a patent for Effexor-XR that delayed the release of cheap versions of the anti-depressant is at the centre of a trial starting Monday in Sydney pitting four generic drug makers against pharmaceutical giant Wyeth.